O ROURKE & COMPANY Inc Grows Stock Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

O ROURKE & COMPANY Inc boosted its position in iShares Biotechnology ETF (NASDAQ:IBB) by 3.5% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,859 shares of the financial services provider’s stock after buying an additional 234 shares during the quarter. O ROURKE & COMPANY Inc’s holdings in iShares Biotechnology ETF were worth $999,000 at the end of the most recent quarter.

Other hedge funds have also made changes to their positions in the company. SeaCrest Wealth Management LLC lifted its holdings in iShares Biotechnology ETF by 4.8% in the 1st quarter. SeaCrest Wealth Management LLC now owns 3,503 shares of the financial services provider’s stock valued at $481,000 after acquiring an additional 159 shares during the last quarter. Ashton Thomas Private Wealth LLC boosted its stake in iShares Biotechnology ETF by 50.9% in the 1st quarter. Ashton Thomas Private Wealth LLC now owns 5,291 shares of the financial services provider’s stock valued at $726,000 after buying an additional 1,784 shares in the last quarter. SpiderRock Advisors LLC bought a new stake in iShares Biotechnology ETF during the 1st quarter worth approximately $213,000. Sequoia Financial Advisors LLC raised its position in iShares Biotechnology ETF by 16.9% in the 1st quarter. Sequoia Financial Advisors LLC now owns 2,409 shares of the financial services provider’s stock worth $331,000 after purchasing an additional 349 shares during the last quarter. Finally, Bray Capital Advisors lifted its holdings in iShares Biotechnology ETF by 1.0% in the first quarter. Bray Capital Advisors now owns 18,856 shares of the financial services provider’s stock valued at $2,587,000 after buying an additional 180 shares during the period. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Down 1.4 %

Shares of iShares Biotechnology ETF stock traded down $2.01 during trading hours on Thursday, hitting $140.40. The company’s stock had a trading volume of 685,968 shares, compared to its average volume of 1,444,568. The stock has a 50 day moving average of $145.24 and a 200 day moving average of $140.27. iShares Biotechnology ETF has a 12 month low of $111.83 and a 12 month high of $150.57.

iShares Biotechnology ETF Dividend Announcement

The company also recently announced a dividend, which was paid on Monday, September 30th. Stockholders of record on Wednesday, September 25th were given a $0.2005 dividend. The ex-dividend date was Wednesday, September 25th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.